Opportunities

Baxter/Hill-Rom Helux Pro Surgical Light System

Sources Sought from National Institutes of Health, solicitation 75N98027Q00038SB_PCA-NIA-11810. Responses due Dec 8, 2026. NAICS 339112, Small Business Set Aside - Total. Listed on SAM.gov.

Solicitation
75N98027Q00038SB_PCA-NIA-11810
Notice type
Sources Sought
Department
Health and Human Services, Department of
Agency
National Institutes of Health
Office
National Institutes of Health Olao
Posted
Nov 16, 2026
Responses due
Dec 8, 2026
Product/service code
6515
Set-aside
Small Business Set Aside - Total
Place of performance
Brooklyn, MD
Listed on
SAM.gov

Description

The National Institute on Aging (NIA), Intramural Research Program (IRP), operates the Clinical Research Unit (CRU) located at the MedStar Harbor Hospital campus in Baltimore, Maryland. The CRU serves as the primary dedicated clinical facility supporting human longitudinal and translational aging research protocols, including the Baltimore Longitudinal Study of Aging (BLSA), the Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT) study, and specialized clinical trials investigating age-related functional decline and metabolic disorders. A cornerstone of these intramural clinical protocols involves invasive outpatient biopsy procedures�specifically percutaneous skeletal muscle biopsies, subcutaneous adipose tissue biopsies, and dermal skin punch biopsies. These procedures provide vital biospecimens for cellular, molecular, and physiological characterization of human aging. The existing ceiling-mounted surgical lighting system currently deployed in the CRU procedure suite has reached the end of its useful service life (End-of-Life / EOL). The legacy unit is experiencing persistent operational failures. Critical replacement parts are no longer manufactured or supported by the original equipment manufacturer (OEM), rendering the existing unit non-serviceable. Because medical-grade illumination is a non-negotiable safety and operational prerequisite for procedural asepsis, precise anatomical depth perception, tissue differentiation, and hemostasis, the current state presents an unacceptable clinical risk and threatens immediate disruption to approved NIA protocol timelines.

Loading the opportunity